Zhan Wang

No. 415 Fengyang Road
Shanghai, 200003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Human Gallbladder Cancer Organoids.

Human Gallbladder Cancer Organoids.

Journal: Cell proliferation

Published: March 02, 2026

Targeted therapy in advanced BRAF-mutated colorectal cancer: systematic review and network meta-analysis.

Targeted therapy in advanced BRAF-mutated colorectal cancer: systematic review and network meta-analysis.

Journal: BMJ (Clinical research ed.)

Published: December 08, 2025

Adaptive Exposure Optimization for Underwater Optical Camera Communication via Multimodal Feature Learning and Real-to-Sim Channel Emulation.

Adaptive Exposure Optimization for Underwater Optical Camera Communication via Multimodal Feature Learning and Real-to-Sim Channel Emulation.

Journal: Sensors (Basel, Switzerland)

Published: September 23, 2025

Anlotinib plus sintilimab as first-line treatment for patients with advanced colorectal cancer (APICAL-CRC): an open-label, single-arm, phase II trial.

Anlotinib plus sintilimab as first-line treatment for patients with advanced colorectal cancer (APICAL-CRC): an open-label, single-arm, phase II trial.

Journal: Signal transduction and targeted therapy

Published: January 12, 2025

Anlotinib plus toripalimab as a first-line treatment in patients with advanced gastric cancer and performance status 2: the phase II APICAL-GC trial.

Anlotinib plus toripalimab as a first-line treatment in patients with advanced gastric cancer and performance status 2: the phase II APICAL-GC trial.

Journal: Nature communications

Published: January 05, 2025

Quantification of β-Elemene by GC-MS and Preliminary Evaluation of Its Relationship With Antitumor Efficacy in Cancer Patients.

Quantification of β-Elemene by GC-MS and Preliminary Evaluation of Its Relationship With Antitumor Efficacy in Cancer Patients.

Journal: Journal of analytical methods in chemistry

Published: September 19, 2024

Impact of molecular tumor board on clinical outcomes in patients with refractory solid tumors: a real-world study.

Impact of molecular tumor board on clinical outcomes in patients with refractory solid tumors: a real-world study.

Journal: The oncologist

Published: April 01, 2024

Impact of Molecular Tumor Board on Clinical Outcomes in Patients with Refractory Solid Tumor: a Real-World Study.

Impact of Molecular Tumor Board on Clinical Outcomes in Patients with Refractory Solid Tumor: a Real-World Study.

Journal: The oncologist

Published: April 01, 2024

New clinical trial design in precision medicine: discovery, development and direction.

New clinical trial design in precision medicine: discovery, development and direction.

Journal: Signal transduction and targeted therapy

Published: November 30, 2023

Clinical Advances and Future Directions of Oncolytic Virotherapy for Head and Neck Cancer.

Clinical Advances and Future Directions of Oncolytic Virotherapy for Head and Neck Cancer.

Journal: Cancers

Published: September 20, 2023

Pan-cancer efficacy and safety of anlotinib plus PD-1 inhibitor in refractory solid tumor: A single-arm, open-label, phase II trial.

Pan-cancer efficacy and safety of anlotinib plus PD-1 inhibitor in refractory solid tumor: A single-arm, open-label, phase II trial.

Journal: International journal of cancer

Published: January 19, 2023

Membrane-associated RING-CH protein (MARCH8) is a novel glycolysis repressor targeted by miR-32 in colorectal cancer.

Membrane-associated RING-CH protein (MARCH8) is a novel glycolysis repressor targeted by miR-32 in colorectal cancer.

Journal: Journal of translational medicine

Published: February 14, 2022

Showing 1-12 of 29

Last Updated: 09/26/2026